LONDON, UK / ACCESSWIRE / February 28, 2017 / Active Wall St. blog coverage looks at the headline from Brocade Communications Systems, Inc. (NASDAQ: BRCD). Ruckus Wireless, a part of Brocade Communication Systems, announced on February 27, 2017, a collaboration where it has agreed to work with Amdocs (NASDAQ: DOX), a leading software, and service to communication provider, to deliver customizable and managed cloud Wi-Fi service to service providers across the world. The Ruckus Service Provider banks on industry-leading access points and cloud-managed and hosted, virtualized software platform to deliver vertically integrated Wi-Fi and LTE offerings as managed services. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

Today, AWS is promoting its blog coverage on BRCD and DOX. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Prospects from the Agreement

This collaboration with Amdocs is viewed as an opportunity to deliver advanced solutions to clients, which provide added flexibility and customization. Amdocs, owing to its operation span of more than 30 years, is competent enough to deliver managed services to communications and media service providers. Amdocs is set to strengthen Ruckus’s portfolio and expand the Company’s efforts to enable service providers with Wi-Fi and LTE solutions.

This agreement is beneficial to the service providers as it offers minimal operational expenses with reduced internal R&D investment and ongoing lifecycle management to deliver differentiated solutions rapidly. In other words, service providers will now have the feasibility to customize managed services offering for unique needs where they can install it in the cloud of their choice and integrate it with multiple management systems and support packages.

Ruckus’s Growth Portfolio

This collaboration with Amdocs is viewed as an opportunity to deliver a level of differentiation and control for wireless LAN offerings, not yet experienced by a majority of service providers before. The collaboration is set to strengthen Company’s stronghold into the sector while creating new market diversification opportunities for both the Companies.

Amdocs currently operates across more than 85 countries with a workforce of 25,000 employees. For the FY16, Amdocs reported net full-year revenues of $3.7 billion.

Public Internet Service Initiatives

Ruckus Wireless, a part of Brocade, additionally announced an agreement with Intersection, an urban experience Company, on February 27, 2017, to deliver high-speed public Wi-Fi to city streets and transit hubs around the globe. The Company aims to bank on the rapidly developing smartphone and IoT infrastructure where it would deliver free, sustainable connectivity through the convergence of world-class wireless technology, digital services, and a viable business model, backed by advertising.

Ruckus plans to leverage the portfolio and infrastructure from the lead Company behind LinkNYC, to deliver free gigabit public Wi-Fi while using reliable and high-performance connection from the Company. LinkNYC is probably the largest and fastest free public Wi-Fi initiative in the world. The project is set to be expanded to London and other cities across the United Kingdom.

Enterprise Managed Services Portfolio

Ruckus Wireless, in addition to the Public Wi-Fi initiative and solutions for service providers, announced a fully customized solution to deliver high-value managed services for enterprise customers on February 27, 2017. Ruckus’s flagship service, Ruckus Service Provider (SP) Cloud is a managed service offering aimed at delivering enterprise Wi-Fi through the Company’s industry-leading access points while designing platform for the upcoming LTE service through the Ruckus’ OpenG technology, and wired networking through Brocade ICX switches.

Ruckus SP Cloud enables service providers to deliver as per their brand value while monitoring the required resources and fastening the time-to-market gap while enabling them to develop one of the largest and fastest growing presences in the enterprise managed services market. Ruckus SP Cloud is designed to be customizable, deployable, and managed by system integrators while offering a flexible and cost-effective platform for multiple high-performance enterprises managed networking services.

Brocade Growth Strategies

Prior to this agreement, last week, on February 22, 2017, Arris International PLC (NASDAQ: ARRS) announced an agreement where ARRIS along with Broadcom will acquire Brocade Communication Systems Inc.’s Ruckus Wireless and ICX Switch business for approximately $800 million, excluding the additional unvested employee stock awards. Ruckus’s portfolio is set to be accretive to Broadcom’s platform where the Company would deliver wired and wireless networking technologies across multiple institutions.

Brocade has aimed for inorganic growth in the public sector by offering free Wi-Fi services while leveraging on advertising for revenues, hence executing a definitive growth strategy to deliver added cash inflows for the Company.

Earnings Highlights

Brocade released its Q1 FY17 results on February 23, 2017, where it reported net revenues of $581 million for the three-month period.

Stock Performance

At the close of trading session on February 27, 2017, Brocade Communications Systems’ share price finished the trading session at $12.32, slightly sliding 0.08%. A total volume of 2.95 million shares exchanged hands. The stock has advanced 19.03% and 26.71% in the last six months and past twelve months, respectively. Furthermore, the stock is trading at a PE ratio of 44.32 and has a dividend yield of 1.79%. At Monday’s closing price, the stock’s net capitalization stands at $5.03 billion.

At the closing bell, on Monday, February 27, 2017, Amdocs’ stock marginally climbed 0.07%, ending the trading session at $60.80. A total volume of 970.71 thousand shares were traded at the end of the day, which was higher than the 3-month average volume of 641.45 thousand shares. In the last month and previous twelve months, shares of the Company have advanced 3.81% and 7.10%, respectively. Moreover, the stock gained 4.38% since the start of the year. The stock currently has a market cap of $8.87 billion. The Company’s shares are trading at a PE ratio of 22.52 and have a dividend yield of 1.45%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456183

“We have always known that heedless self interest was bad morals, we now know that it is bad economics.” – Franklin D. Roosevelt

NEW YORK, NY / ACCESSWIRE / February 28, 2017 / As longstanding shareholders of Edgewater Technology, Inc. (“Edgewater” or the “Company”) (NASDAQ: EDGW) we were thrilled to read that Ancora Advisors’ successful consent solicitation had resulted in a dramatic reconstitution of Edgewater’s Board of Directors (the “Board”). We believe that finally (after years of what we consider to be shameful and inexcusable performance) the Board now consists of members who are qualified and motivated to act in the best interests of all shareholders.

For several years we have been highly critical of Edgewater’s Chairman and CEO, Shirley Singleton, and felt she was dramatically overpaid (especially considering the poor performance of the Company’s stock price). Our public letters to the Board dated (i) November 19, 2012, (ii) February 5, 2013, (iii) October 10, 2013 and (iv) December 18, 2013 (which came only after extensive but unsuccessful private communications) and information provided in Ancora’s proxy solicitation documents illustrate the staggering compensation Ms. Singleton has received during her tenure and the questionable business practices that we believe have occurred during this time.

We have also been highly critical of other former members of the Board who we believe repeatedly failed to act in the best interests of all shareholder. We believe many of these Board members lacked the skill set and incentives necessary to create shareholder value and we question why they were ever nominated to the Board in the first place. We fail to understand how Daniel O’Connell, Nancy L. Leaming, Paul E. Flynn, Paul Guzzi, Michael R. Loeb, Shirley Singleton and Wayne L. Wilson can justify their longstanding and well compensated tenure on the Board and we hope anyone considering doing business with these individuals will closely examine their track record at Edgewater.

We feel it is unfortunate that the old Board chose to waste so much time and money fighting initiatives that we believe were clearly in the best interests of all shareholders. However, we are highly confident that the new Board will not make the same mistakes.

Sincerely,

Ephraim Fields
Echo Lake Capital

Contact:

Ephraim Fields at (212) 251-3381

SOURCE: Echo Lake Capital

ReleaseID: 456066

Clients Now Have Access to a Technology-Enabled Solution to Obtain a Signature Medallion Guarantee

NEW YORK, NY / ACCESSWIRE / February 28, 2017 / eSignatureGuarantee.com, a unique online digital platform for shareholders, today announced that Direct Transfer, a division of Issuer Direct Corp. (NYSE MKT: ISDR), has selected the eSignatureGuarantee.com platform to provide shareholders with a modern solution to obtain a medallion signature guarantee.

Direct Transfer is the latest stock transfer agent to align with eSignatureGuarantee.com in order to simplify the security transfer process for investors. A medallion signature, which verifies a customer’s identity and helps protect shareholders from fraud, is a requirement when transferring securities. eSignatureGuarantee.com leverages ID Verification technology through a web-based platform to simplify and modernize the process, allowing shareholders and investors to obtain the requirements needed more efficiently and quickly.

“We are very excited to be working with eSignatureGuarantee.com,” said Eddie Tobler, Vice President of Stock Transfer at Issuer Direct Corp. “We are always looking to provide more efficient solutions to our clients and shareholders, and this technology will significantly alleviate some of the pain-points associated with obtaining a medallion signature, ultimately saving clients both time and money.”

Obtaining a medallion signature has become increasingly difficult and time-consuming, as many banks, credit unions, and financial institutions have simply stopped offering this service, leaving shareholders with nowhere else to turn. eSignatureGuarantee.com is the only digital platform that offers this service through an online solution. By continuing to collaborate with stock transfer agents, shareholders, and funds, the shareholder community now has a more efficient, modern, and fully-compliant solution to obtain a signature medallion.

About Direct Transfer

Direct Transfer is a division of Issuer Direct Corp., which is an industry-leading communications and compliance company focusing on the needs of corporate issuers. Issuer Direct’s principal platform, Platform ID, empowers users by thoughtfully integrating the most relevant tools, technologies, and services, thus eliminating the complexity associated with producing and distributing financial and business communications. Headquartered in RTP N.C., Issuer Direct serves more than 2,000 public and private companies in more than 18 countries.

About eSignature Group, LLC

eSignature Group provides a unique, patent pending online platform at eSignatureGuarantee.com, which allows stockholders to obtain a medallion signature guarantee for the transfer of securities. The platform is available for individuals, corporate entities, trustees, and executors and can be used to obtain a medallion signature guarantee for shares in physical certificate form or for shares held in an electronic book entry account via the submission of a signed stock power. For more information, visit www.esignatureguarantee.com.

Contact:

PR
Lauren Herman
Caliber Corporate Advisers
lauren@calibercorporate.com
952.221-4615

Direct Transfer
Eddie Tobler
Vice President of Stock Transfer
eddie.tobler@issuerdirect.com
919.744.2722

SOURCE: eSignatureGuarantee.com

ReleaseID: 455945

VANCOUVER, BC / ACCESSWIRE / February 28, 2017 / As Saudi Arabia cuts even more oil than promised, U.S. shale production is up by 176,000 barrels per day—but it’s the frac sand industry that will feel the real revolution, and micro-cap sand producers who have flown under the radar until now are about to come up for some very lucrative air.

But the U.S. shale rebound started even before the historical OPEC deal—so we’re already running out of time to get in on the frac sand euphoria.

Last week, the Saudis said they had cut production to below 10 million barrels per day, which is a two-month low, and lower than the Kingdom had pledged to cut. At the same time, the Energy Information Administration (EIA) came out with news of a 176,000-barrel-per-day increase in U.S. production from the previous week—the biggest increase since May 2015.

The shale rebound started when no one expected the OPEC deal to become a reality, and now that it is and the market is starting to rebalance, things are about to go much further. The EIA sees U.S. production for December coming in at 320,000 barrels per day more for the year, with production reaching 9.22 million barrels per day as of the end of 2016.

And even this is probably conservative.

But it’s not just about OPEC—it’s about the ‘Mega Frac’—the frac of all fracs that requires a ton of sand and is making it possible for U.S. shale operators to produce in any kind of market.

Hydraulic fracturing involves injecting highly pressurized water and sand into a well, widening the tiny fractures created by the water and sand blast so that more crude oozes from the shale rock. As U.S. producers create more fractures in rock to get ore oil and gas out, they need the ‘Mega Frac’, which requires mega sand to keep the fractures open.

Producers are now using more sand, or proppants, per well than anyone ever imagined, bringing the frac sand sub-sector to the forefront of oil and gas investing in a very urgent and dramatic way.

So the bottom-line situation is this: While frac sand companies are at the center of the U.S. shale rebound, unique micro-cap sand miners like Select Sands (TSX.V:SNS) (OTCQB:SLSDF) are poised for potentially astounding gains precisely because as early as mid last year, no one thought frac sand would be a winning bet and only a few months later, it’s the biggest thing on the U.S. oil and gas scene.

Here are 3 reasons to keep a close eye on Select Sands (TSX.V:SNS) (OTCQB:SLSDF) and its substantial permitted quarry in Arkansas containing a desirable mix of Premium Tier 1 “Ottawa White” high purity 40/70 and 100 mesh silica.

#1 Most Explosive Oil & Gas Sub-Sector

Tudor Pickering predicts the amount of sand used per horizontal well will jump from 8 million pounds (4,000 tons) today to a staggering 11 million pounds (6,500 tons) already next year, and will continue to break records in the following years.

Credit Suisse predicts a 50 percent increase on 2015 demand and is eyeing 62.8 million tons of frac sand demand in 2018. In 2017, we could be looking at 49.4 million tons.

By 2018, according to Credit Suisse analysts, sand volumes used in fracking will surpass the boom levels of 2014, making frac sand the “fastest-growing sub-segment” in the oilfield services and equipment market.

It’s been great for frac sand stocks, with U.S. Silica (SLCA) jumping from $16 to $40 this year, but from an investment perspective, there aren’t many plays to choose from here. And there’s really only one micro-cap listed that is geographically positioned to benefit from this shale efficiency revolution: Select Sands Corp. (TSXV-V:SNS). Being a micro-cap, Select Sands is flying under the radar (at least for now) and has no analyst coverage.

#2 Preparing for ‘Mega Demand’

Not only have frac sand stocks had a great few months, but the fundamentals behind that surge are clear and present. Smart Sand held its IPO in early November in what Reuters called “another sign of industry confidence”.

Companies such as U.S. Silica, Emerge Energy Services LP and Hi Crush Partners LP all had saw an increase in business as far back as the third quarter of last year—before the OPEC deal was even close to being a reality. Texas-based Rangeland Energy LLC says it’s looking to expand its frac sand transport and storage capabilities because volume is soaring enough to double up. Hi Crush is expecting double-digit volume increases in the fourth quarter. And this is all just a snippet of the bigger picture as we get into 2017.

And demand is poised for an amazing upward spiral because frac sand is the backbone of shale companies’ efforts to cut costs and improve efficiency by increasing their yields of oil and gas per well.

The more sand used in a well, after the pressurized liquid and sand is injected in the rock, the larger the fractures in the rock oozing precious oil and gas. Thanks to sand, you get a lot more oil and gas out of a well at no great additional cost.

All the major U.S. shale drillers are ramping up their sand use exponentially. EOG Resources (EOG) is now making 700 percent more fractures compared to 2010, and it’s using massive volumes of sand to fill them. Likewise, Chesapeake (CHK) put more than 30 million pounds (15,000 tons) of sand into its Haynesville shale in Louisiana, and plans to test a 50-million-pound load (25,000 tons) later this year. The company views the amount of sand now being used as unprecedented to the point that it refers to it as “proppant-geddon“.

The Permian Basin is the one of the sweetest spots here because operators just can’t get enough sand as drillers narrow in on this West Texas gem with an acquisition fervor we haven’t seen since the start of the shale boom. Here, proppant demand is expected to increase significantly as the Permian catches up with other basins in terms of frac sand use.

The bottom line? Demand for sand in 2017, particularly the finer grade (40/70 and 100 mesh) high purity sand contained in Select Sands’ Arkansas quarry, could end up being twice the demand of 2014—at the height of the shale boom. There may even be a shortage of finer grade frac sand by the first quarter of 2017.

#3 Purest Sand for Strongest Margin Expansion

Select Sands (TSX.V:SNS) (OTCQB:SLSDF) is right in the middle of what Tudor Pickering views as the oilfield services sector with the strongest margin expansion—and this expansion is far from over. Tudor Pickering says finer mesh white sand pricing at the minegate should reach $65 per ton, compared to the current $20 per ton.

Select Sands mines high-quality Northern White finer grade sand from the Sandtown deposit in Arkansas, with indicated resources of 41.98 million tons as of February this year. The sand is high-purity, meaning it contains a high purity silica content (exceeding or meeting various industrial and API Tier 1 specifications) with the right shape and it has high crush resistance. The right shape for good frac sand is as close to round as possible, which enables more efficient infiltration of rock fractures to keep it open and keep the oil flowing.

Margins are also increased here because Select Sands’ Sandtown quarry is located in northeastern Arkansas, in close proximity to the Permian and the Eagle Ford plays in Texas, Haynesville shale in Louisiana and Fayetteville shale in Arkansas. This means there is a lot to be saved on transportation costs, compared with the other main source of high-quality (but expensive) frac sand located in Wisconsin. The Select Sands’ quarry also has the added advantage of a developed transport infrastructure with easy accessibility to both highway and railway that could be used to further improve costs.

And the shift is about more than transportation: It’s about the industry’s cost-cutting desires to replace the more expensive sand mined in Wisconsin and Minnesota with regional sands of Texas and Arkansas.

Select Sands recently announced that it bought a wet processing facility that will further reduce costs of production and make its sand all the more appealing for the frugal oil and gas industry. The Company plans on buying a dry plant and other facilities as well in the area and is currently considering its options.

There’s even more upside:

High-purity finer grade silica sand is not just used for fracking. It’s indispensable in ceramics, metal-making, chemical products, glass, paints, and surfacing materials. In other words, Select Sands, which mined its first silica sand at Sandtown last year, is successfully providing test samples of its high mesh silica to a host of industrial companies, and has recently started shipping product to the oil and gas market. Selling high-purity finer mesh white sand to the industrial market has the advantage of higher margins, although typically smaller volumes, than sales to the oil and gas frac sand market.

At the end of the day, these frac sand producers tend to fly under the radar while everyone pays attention to the most visible players in the U.S. shale revival. That give companies like Select Sands a major advantage at a time when pure-play sand mining is a clear winner and frac sand mining is set to explode dramatically and suddenly.

Of the handful of public frac sand producers out there, most are too big to get in on the ground floor—and too expensive. Select Sands, with a $88MM U.S. market cap, is accessible, cheap, and the timing is brilliant.

Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of Baystreet.ca only and are subject to change without notice. Baystreet.ca assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.

Contact:

Aaron Bodnar

aaron@baystreet.ca

SOURCE: Baystreet Media Corp.

ReleaseID: 456176

Basal cell carcinoma and squamous cell carcinoma (skin cancers) selected, representing over 5,500,000 diagnoses annually in the
US alone, making it the most prevalent cancer today

KENNEWICK, WA / ACCESSWIRE / February 28,
2017 / Advanced Medical Isotope Corporation (“AMI”) (OTC PINK: ADMD), a cancer therapeutics company focused on the commercialization of their RadioGel™ device, a tumor-injectable and biodegradable radiation that remains focused at the treatment site, today released the third letter in a four letter series outlining AMI’s push towards FDA submittal and commercialization from its new President & CEO, Dr. Mike Korenko.

Dear Shareholders,

After two months of dynamic experience-based discussions among our Medical Advisory Board Members and other senior doctors we have selected our first indication for use which we will present to the Food and Drug Administration.

After thorough review to prioritize indications, we have selected basal
cell and squamous cell carcinoma (skin cancers). The reasons for this important selection relates to our criteria below:

1. POTENTIAL FOR FDA APPROVAL AND SUCCESSFUL THERAPY:

a. Accessibility, ease of application:

This cancer is in the skin and therefore easy to access. Single injections for small tumors are easy and we have already demonstrated our
parallel injection procedure in the cat at Washington State University for
larger tumors.

b. Therapeutic ratio (ratio of the dose to the tumor target tissue
relative to dose to adjacent normal tissue) and responsiveness to radiation:

Yttrium-90 is a beta emitter in RadioGel has a
much higher therapeutic ratio than any gamma emitter or external beam therapy.
Since Y-90 delivers high-energy beta-rays, it has an average penetration path
of 4 to 5 mm (less than a quarter inch), which is ideal for skin cancer
therapy. There is minimal irradiation of normal surrounding tissue. As an added bonus, the patent can go home
immediately with no irradiation risk to themselves or family members.

We can treat with very high doses, so response
to radiation would not be an issue. (As a comparison, external beam radiation
can deliver 60 to 80 Gy. Yttrium-90 in RadioGel can go to 700 Gy or higher).

c. Potential collateral risks from injection:

As discussed above, there is very low risk of
collateral damage. In addition, the skin is not located next to a major organ,
for example if you were injecting near spinal tumors.

d. FDA Testing requirements:

Because of the low collateral risk and because
of the therapeutic effects that would be relatively easy to see in three months,
the Medical Advisory Board felt this might be an easier device for the FDA to approve and in a shorter timeframe. In addition, some of our animal testing, that
will start in about two months, are already treating similar cancers.

We intentionally avoided applying to the FDA
for melanoma, since it is highly metastatic and goes deep into the tissue.
There are a much smaller number of cases for this cancer type (around 300,000).
In addition, there are three new immunotherapy products on the market to treat
melanoma cancer. They can have serious side-effects, but they are promising.
That violates our next criterion below.

2. NOTABLE ADVANTAGE OVER CURRENT THERAPIES:

Some skin cancers require several-hour long
surgeries in which the tumor is removed, one layer at a time, and then sent for
biopsy. They then require a skin graft that can lead to an infection. On tumors
of the face this can be disfiguring. As people get older their skin gets
thinner, which increases the difficulty. Our Advisory Board felt that for these
cases in particular RadioGel has a significant therapeutic advantage. It would
be comparatively benefit the patient and contribute to reducing the cost of
health care.

3. CAN BE PROFITABLY EMBRACED BY THE MEDICAL COMMUNITY:

a. Number of patients:

One out or every three new cancers in the
United States is a cancerous skin lesion. The two skin cancer types that we
selected are the most common. There are 3.3 million patients in the United
States with 5.5 million tumors (some patients have more than one tumor.) About
1 million of these are squamous cell cancers located near the surface of the
epidermal skin layer, and greater than 4 million are basal cell cancers in the
deep layer of the epidermis. I would never say that we can treat them all; that
would just be marketing hype, but I believe that this will be the preferred
treatment in a substantial number of cases in a very large market.

b. Ease of acceptance by the medical community, Medicare
reimbursement:

The potential lower cost of RadioGel therapy coupled with the
potential very large number of patients satisfied this criterion. To further
test the criterion, we are in discussions with a major private clinic with
several skin treatment centers. This client believes this is a great new tool for their
toolbox. They are also advising us on the obstacles that will have to be
overcome, such our Medicare reimbursement criterion. Since we believe RadioGel
therapy will reduce the cost to Medicare we are confident that will not be an
obstacle.

There are other cancer types on our list of eighteen potential indications of use for RadioGel, and we have already prioritized to present them to the FDA in the future. Unfortunately, in the meantime, those patients will not be befitting from this technology.

As I have reported in my last shareholder letter, I am aligning the veterinarian animal testing with the human skin cancer. Specially, the University of Missouri will be focusing on the treatment for surface soft cell lesions, and Colorado State University will be refining the therapies for oral squamous cell cancers.

After this selection, our next step is to prepare for the FDA pre-submittal meeting. We will request that meeting after we complete the test plans that will answer their previous questions. Until we complete these plans I can only estimate that our pre-submission to the FDA would be in June. I am really happy that we have engaged John Smith from Hogan Lovells to be at our side through this FDA process.

I am excited and relieved that this selection decision had been made and I wanted to thank the members of our Medical Advisory Board – Chairman Dr. Barry D. Pressman, Dr. Albert DeNittis, Dr. Howard Sandler, and Dr. Darrell Fisher. I would also like to thank Dr. Ricardo Paz-Fumagalli and Dr. Beau Bosko Toskich from the Mayo Clinic for their valuable advice.

In addition to the important developments discussed above, we continue to believe that the public markets are significantly undervaluing our company. With a fully diluted enterprise value of less than $10 million, there remains very large upside potential. As we progress on our plan, I intend to work vigorously to educate and inform the medical and investment community as to the therapeutic benefits our core technology as well as the economic model that can generate significant revenue and profits. We are committed to pursuing an uplisting to a national exchange as soon as possible in order to gain wider exposure and credibility in our pursuit of the multi-billion-dollar addressable market for Radiogel™, that can both significantly improve patient outcomes and reward shareholders.

Dr. Mike Korenko
President and CEO (acting), Advanced Medical Isotope and IsoPet

About Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation (ADMD) is a late stage radiation oncology focused medical device company engaged in the development of yttrium-90 based brachytherapy devices for cancer treatment. The IsoPet Solutions division is focused on utilizing RadioGel for a cancer therapy in animals. Brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area. The Company intends to outsource material aspects of manufacturing, distribution, sales and marketing for its products in the United States and to enter into licensing arrangements outside of the United States, though the Company will evaluate its alternatives before finalizing its plans. For more information, please visit our websites: www.isopetsolutions.com and www.isotopeworld.com.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimates,” “projects,” “intends,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company’s ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company’s control.

CONTACT:

Company Contact:

Advanced Medical Isotope
Dr. Mike Korenko, President & CEO

Investors:

Circadian Group IR
Tyler Troup, B. Comm
info@Circadian-group.com
877-950-8300

SOURCE: Advanced Medical Isotope Corporation

ReleaseID: 456167